Predicting dementia: Role of dementia risk indices

Future Neurology

Volumn 4, Issue 5, 2009, Pages 555-560

  Barnes, Deborah E ^a   Yaffe, Kristine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dementia; Prevention; Risk assessment; Risk factors

Indexed keywords

ALZHEIMER DISEASE; BREAST CANCER RISK ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; DEMENTIA; EARLY DIAGNOSIS; FRAMINGHAM HEART INDEX; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LATE LIFE DEMENTIA RISK INDEX; MID LIFE DEMENTIA RISK SCORE; PATIENT IDENTIFICATION; PATIENT MONITORING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; UNITED STATES;

EID: 75249099991     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/fnl.09.43     Document Type: Review

References (43)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60(8), 1119-1122 (2003).
2. Raina P, Santaguida P, Ismaila A et al.: Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann. Intern. Med. 148(5), 379-397 (2008).
3. Rosenberg RN: Translational research on the way to effective therapy for Alzheimer disease. Arch. Gen. Psychiatry 62(11), 1186-1192 (2005).
4. Jorm AF, Jolley D: The incidence of dementia: a meta-analysis. Neurology 51(3), 728-733 (1998).
5. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88(9), 1337-1342 (1998). ■ Descibes that delaying onset of Alzheimer's disease by as little as 1 or 2 years could prevent millions of individuals from ever developing symptoms.
6. Qiu C, De Ronchi D, Fratiglioni L: The epidemiology of the dementias: an update. Curr. Opin. Psychiatry 20(4), 380-385 (2007).
7. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12(3), 189-198 (1975).
8. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A: The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int. J. Geriatr. Psychiatry 15(11), 1021-1027 (2000).
9. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1), 29-36 (1982).
10. Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA: Regression modelling strategies for improved prognostic prediction. Stat. Med. 3(2), 143-152 (1984).
11. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15(4), 361-387 (1996).
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97(18), 1837-1847 (1998). ■ Describes development of the original Framingham Heart Index, which uses an individual's age, diabetes status, smoking status, blood pressure and cholesterol level to predict risk of experiencing a major coronary event within 10 years. The Framingham Heart Index is widely used in clinical settings as a simple method for identifying high-risk individuals and targeting them for intervention and prevention.
13. Gail MH, Brinton LA, Byar DP et al.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl Cancer Inst. 81(24), 1879-1886 (1989). ■ Describes development of the Breast Cancer Risk Assessment Tool, which uses information regarding a woman's age, race, reproductive history, family history of breast cancer and biopsy history to predict her risk of developing invasive breast cancer within 5 years.
14. Gail MH, Costantino JP, Pee D et al.: Projecting individualized absolute invasive breast cancer risk in African American women. J. Natl Cancer Inst. 99(23), 1782-1792 (2007).
15. Lindstrom J, Tuomilehto J: The diabetes risk score: a practical tool to predict Type 2 diabetes risk. Diabetes Care 26(3), 725-731 (2003).
16. Schulze MB, Hoffmann K, Boeing H et al.: An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of Type 2 diabetes. Diabetes Care 30(3), 510-515 (2007).
17. Walter LC, Brand RJ, Counsell SR et al.: Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 285(23), 2987-2994 (2001).
18. Lee SJ, Lindquist K, Segal MR, Covinsky KE: Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295(7), 801-808 (2006).
19. Gao S, Hendrie HC, Hall KS, Hui S: The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55(9), 809-815 (1998).
20. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271(13), 1004-1010 (1994).
21. Tang MX, Cross P, Andrews H et al.: Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56(1), 49-56 (2001).
22. MacKnight C, Rockwood K, Awalt E, McDowell I: Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement. Geriatr. Cogn. Disord. 14(2), 77-83 (2002).
23. Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4(8), 487-499 (2005).
24. Zhu L, Fratiglioni L, Guo Z et al.: Incidence of dementia in relation to stroke and the apolipoprotein E e4 allele in the very old. Findings from a population-based longitudinal study. Stroke 31(1), 53-60 (2000).
25. Corder EH, Saunders AM, Strittmatter WJ et al.: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261(5123), 921-923 (1993).
26. Lindsay J, Laurin D, Verreault R et al.: Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 156(5), 445-453 (2002).
27. Wilson RS, Mendes De Leon CF, Barnes LL et al.: Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 287(6), 742-748 (2002).
28. Luchsinger JA, Noble JM, Scarmeas N: Diet and Alzheimer's disease. Curr. Neurol. Neurosci. Rep. 7(5), 366-372 (2007).
29. Anstey KJ, von Sanden C, Salim A, O'Kearney R: Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol. 166(4), 367-378 (2007).
30. Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT Jr, Mittleman MA, Siscovick DS: Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 289(11), 1405-1413 (2003).
31. Jorm AF: History of depression as a risk factor for dementia: an updated review. Aust. NZ J. Psychiatry 35(6), 776-781 (2001).
32. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B: Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 355(9212), 1315-1319 (2000).
33. Tierney MC, Yao C, Kiss A, McDowell I: Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64(11), 1853-1859 (2005).
34. Peres K, Helmer C, Amieva H et al.: Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J. Am. Geriatr. Soc. 56(1), 37-44 (2008).
35. Wang L, Larson EB, Bowen JD, van Belle G: Performance-based physical function and future dementia in older people. Arch. Intern. Med. 166(10), 1115-1120 (2006).
36. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H: Abnormality of gait as a predictor of non-Alzheimer's dementia. N. Engl. J. Med. 347(22), 1761-1768 (2002).
37. Haan MN, Aiello AE, West NA, Jagust WJ: C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype. Neurobiol. Aging 29(12), 1774-1782 (2008).
38. Sundelof J, Arnlov J, Ingelsson E et al.: Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology 71(14), 1072-1079 (2008).
39. Kuller LH, Lopez OL, Newman A et al.: Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22(1), 13-22 (2003).
40. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348(13), 1215-1222 (2003).
41. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J: Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 5(9), 735-741 (2006). ■■ Describes development of the first dementia risk index, the Mid-Life Dementia Risk Score, which uses a combination of demographic and cardiovascular risk factors to predict an individual's risk of developing dementia 20 years later with high accuracy.
42. Barnes DE, Covinsky KE, Kuller LH, Lopez OL, Yaffe K: Predicting an individual's risk of developing dementia: the Cardiovascular Health Cognition Study. Neurology DOI:10.1016/j. jalz.2007.04.356 (2009) (Epub ahead of print). ■■ Describes development of the first dementia risk index, the Mid-Life Dementia Risk Score, which uses a combination of demographic and cardiovascular risk factors to predict an individual's risk of developing dementia 20 years later with high accuracy.
43. Alzheimer's Association: 2009 Alzheimer's Disease Facts & Figures. www.alz.org/national/documents/report- alzfactsfigures2009.pdf (Accessed 6 July 2009). ■ Informative document that provides an excellent summary of current knowledge regarding Alzheimer's disease including prevalence, incidence, costs, risk factors, symptoms and treatments.